Ergotamine Derivative drugs compared
Compare all 5 Ergotamine Derivative drugs side by side, used for conditions such as cluster headache, postpartum hemorrhage, hypotension, orthostatic. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 5 drugs
- 170/100
brekiya (autoinjector)
Dihydroergotamine Mesylate
- 2New
atzumi
Dihydroergotamine Mesylate
- 3New
dihydroergotamine mesylate
Dihydroergotamine Mesylate
- 4New
migranal
Dihydroergotamine Mesylate
- 5New
trudhesa
Dihydroergotamine Mesylate
Frequently asked questions
What is the Ergotamine Derivative drug class?
Ergotamine Derivative is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 5 Ergotamine Derivative products, each independently rated.
Are all Ergotamine Derivative drugs the same?
No. Ergotamine Derivative drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Ergotamine Derivative drugs treat?
Per NIH RxClass drug-classification data, Ergotamine Derivative drugs are used for conditions including cluster headache, postpartum hemorrhage, hypotension, orthostatic, migraine disorders, xerostomia.
Sources: the Ergotamine Derivative class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.